Breaking News: MRHA "CBD Products To Be Removed From Sale in UK"

The pharmaceuticalisation of CBD Products? Today news swept across the internet and social media that Cannabidiol (CBD), the non-psychoactive cannabinoid, is going to be scheduled as a medicine.  A number of CBD companies have received letters from the Medicines and Healthcare products Regulatory Agency (MHRA) notifying them that they will have to cease selling CBD […]

Continue Reading

A Job In The Legal UK Cannabis Industry Has Become Available

Occasionally you hear that “medical cannabis is legal in the UK” when at international cannabis conferences. This is almost an “in black and white” or “down on paper” kind of “medical cannabis” whereby technically there is because there is a pharmaceutical company licenced to produce and research it. They have gone on to make medicines […]

Continue Reading

GW Pharmaceuticals progress with diabetes, epilepsy and schizophrenia cannabis medicines

Clinical trials to use cannabis in the treatment of debilitating illness proving successful for licensed UK company. Whilst the release of their flagship medicine, Sativex and its success in 24 countries around the world has been taking place, GW Pharmaceuticals have been developing more treatment options for illnesses that can benefit from cannabis’ medical components. […]

Continue Reading

Wales Green Party Leader Questions GW Pharma Monopoly

Pippa Bartolotti, leader of the Wales Green Party, has highlighted the blatant hypocrisy regarding the the current cannabis laws, as they protect corporate profits whilst denying everday, disabled people, vital access to medication. The blog post comes after GW Pharmaceuticals have published new profits of over $100million just this month on shares placed on NASDAQ. […]

Continue Reading